Asthma sufferers will be pleased to know there is a new drug on the market to help in the fight of this debilitating disease. The new drug which was approved for the treatment of asthma is called quilizumab. It is for the treatment of persons with mild asthma attacks, and is said to be very effective as reported in Science Translational Medicine.
For persons with more severe conditions, the drug company Genentech (a member of the Roche Group) has scheduled clinical trials these years. This is good news for asthma patients who have found it challenging to keep their attacks under control. Their lifestyles have to change, with regards to living conditions and their working environment. For persons whose triggers are pets, they probably have to get rid of them and for persons that are allergic to dust and dust mites; their entire bedding and furniture has to be changed to alleviate the asthma symptoms.
Because of the limited availability of ready relief the mortality rate is high; especially among the younger age group of sufferers of asthma. The Global Initiative for Asthma shows South Africa’s fatality rate to be the fifth highest in the world at 18.5% out of every 100,000 cases. This is not good so the introduction of this drug quilizumab is very welcome.